Differences in Telemedicine Use Between People With and Without an Intellectual or Other Developmental Disability During the COVID-19 Pandemic
INQUIRY: The Journal of Health Care Organization, Provision, and Financing · 2024
DOI: 10.1177/00469580241226540 ↗Kurz gefasst
Fachartikel in der Zeitschrift INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 2024. Verfasst von Jaewhan Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Utah, Salt Lake City, UT, USA. Hauptthemen laut MEDLINE: COVID-19, Intellectual Disability. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, university of utah.
Abstract (Originalsprache)
Telemedicine utilization of people with an Intellectual or Other Developmental Disability (IDD) during the COVID-19 Pandemic is not well known. This study compares telemedicine utilization of those with and without IDD prior to the pandemic to after it began. Using the Utah All Payers Claims Database from 2019 to 2021, the study identified telemedicine utilization of adults aged 18 to 62 years old in 2019. Propensity score matching was used to minimize observed confounders of subjects with and without IDD in 2019. Negative binomial regression was used to identify factors that were associated with telemedicine utilization. The final number of subjects in the analysis was 18 204 (IDD: n = 6068, non-IDD: n = 12 136 based on 1:2 propensity score matching). The average (SD) age of the subjects was 31 (11.3) years old in 2019. Forty percent of the subjects were female, about 70% of subjects were covered by Medicaid in 2019. Average (SD) number of telemedicine use in 2020 (IDD: 1.96 (5.97), non-IDD: 1.18 (4.90); P < .01) and 2021 (IDD: 2.24 (6.78) vs 1.37 (5.13); P < .01) were higher for the IDD group than the non-IDD group. The regression results showed that the subjects with IDD had 56% more telemedicine encounters than those in the non-IDD group (Incidence Rate Ratio (IRR) = 1.56, P < .01). The growth of telemedicine during the COVID-19 pandemic has the potential to reduce persistent healthcare disparities in individuals with IDD. However, quality of telemedicine should be considered when it is provided to improve health of subjects with IDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Utah, Salt Lake City, UT, USA.
- Indiana University, Bloomington, IN, USA.
- University of Utah Medical Group Population Health, Salt Lake City, UT, USA.
ORCID-Profile: Jaewhan Kim
Förderung
- NCATS NIH HHS
- university of utah
Zitieren
APA
Kim, J., Roy, I., Sanchez, J., Weir, P., Nelson, R., & Jones, K. (2024). Differences in Telemedicine Use Between People With and Without an Intellectual or Other Developmental Disability During the COVID-19 Pandemic. INQUIRY: The Journal of Health Care Organization, Provision, and Financing. https://doi.org/10.1177/00469580241226540
Vancouver
Kim J, Roy I, Sanchez J, Weir P, Nelson R, Jones K. Differences in Telemedicine Use Between People With and Without an Intellectual or Other Developmental Disability During the COVID-19 Pandemic. INQUIRY: The Journal of Health Care Organization, Provision, and Financing. 2024. doi:10.1177/00469580241226540
BibTeX
@article{Kim2024,
author = {Kim, Jaewhan and Roy, Indrakshi and Sanchez, Joseph and Weir, Peter and Nelson, Richard and Jones, Kyle},
title = {Differences in Telemedicine Use Between People With and Without an Intellectual or Other Developmental Disability During the COVID-19 Pandemic},
journal = {INQUIRY: The Journal of Health Care Organization, Provision, and Financing},
year = {2024},
doi = {10.1177/00469580241226540}
}
EUVIMED